Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRBN-DDB1 (Homo sapiens (Human)) | BDBM441811![]() (US10646575, Compound 3) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | 5.01E+5 | n/a | n/a | n/a | n/a | n/a |
C4 Therapeutics, Inc. US Patent | Assay Description Measuring compound ligand binding to CRBN-DDB1 was carried out using an established sensitive and quantitative in vitro fluorescence polarization (FP... | US Patent US10646575 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CRBN-DDB1 (Homo sapiens (Human)) | BDBM441810![]() (US10646575, Compound 2) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a |
C4 Therapeutics, Inc. US Patent | Assay Description Measuring compound ligand binding to CRBN-DDB1 was carried out using an established sensitive and quantitative in vitro fluorescence polarization (FP... | US Patent US10646575 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
CRBN-DDB1 (Homo sapiens (Human)) | BDBM441791![]() (US10646575, Compound 1) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a |
C4 Therapeutics, Inc. US Patent | Assay Description Measuring compound ligand binding to CRBN-DDB1 was carried out using an established sensitive and quantitative in vitro fluorescence polarization (FP... | US Patent US10646575 (2020) | |||||||||||
More data for this Ligand-Target Pair |